中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Filspari
    Filspari
    departments：内科
    drug：片剂
    Active：sparsentan
    indication：减少患有原发性免疫球蛋白A肾病的成人的蛋白尿，有快速疾病进展的风险
    Licensor：Travere Therapeutics, Inc.
    Approved Country/Region：FDA
    Approval time：2023-02-17